How to tailor transcatheter mitral therapies in 2025? A new era

In this discussion from EuroPCR 2025, Mayra Guerrero, Thomas Modine, and Philipp Lurz explore the evolving landscape of mitral valve treatment.

While transcatheter edge-to-edge repair (TEER) remains a safe and effective approach, it doesn't suit every patient. Alternatives like transcatheter mitral valve replacement (TMVR), annuloplasty, and NeoChord implantation are under investigation to expand treatment options.

The field is advancing toward transseptal, transcatheter solutions that may offer better reduction of mitral regurgitation, improved symptoms, and enhanced quality of life. These approaches also allow for future interventions, such as valve-in-valve procedures, providing long-term flexibility.

As the landscape of mitral therapies shifts, questions arise: should comprehensive mitral programs incorporate both repair and replacement strategies? How do we determine the best approach for each patient?

Watch now to gain insights into the future of mitral valve treatments.

This interview was filmed at EuroPCR 2025: see more videos here.